Sarepta Therapeutics Inc logo

Sarepta Therapeutics Inc

LTS:0L35 (USA)   Ordinary Shares
$ 121.67 (0%) Dec 27
78.90
P/B:
9.50
Market Cap:
$ 11.61B
Enterprise V:
$ 11.80B
Volume:
27.00
Avg Vol (2M):
1.59K
Trade In:
Volume:
27.00
Avg Vol (2M):
1.59K

Business Description

Sarepta Therapeutics Inc logo
Sarepta Therapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US8036071004

Share Class Description:

LTS:0L35: Ordinary Shares
Description
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.
Name Current Vs Industry Vs History
Cash-To-Debt 0.86
Equity-to-Asset 0.34
Debt-to-Equity 1.15
Debt-to-EBITDA 7.47
Interest Coverage 4.23
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.48
Distress
Grey
Safe
Beneish M-Score -1.2
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 45.78
9-Day RSI 46.19
14-Day RSI 47.67
6-1 Month Momentum % -18.23
12-1 Month Momentum % 36.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.84
Quick Ratio 3.03
Cash Ratio 1.71
Days Inventory 629.62
Days Sales Outstanding 84.22
Days Payable 180.34

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.7
Shareholder Yield % 0.21

Financials (Next Earnings Date:2025-02-28 Est.)

LTS:0L35's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sarepta Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,640.348
EPS (TTM) ($) 1.54
Beta 0.38
Volatility % 42.54
14-Day RSI 47.67
14-Day ATR ($) 3.334231
20-Day SMA ($) 124.21655
12-1 Month Momentum % 36.52
52-Week Range ($) 88.01 - 175.1
Shares Outstanding (Mil) 95.52

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sarepta Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Sarepta Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Sarepta Therapeutics Inc Frequently Asked Questions

What is Sarepta Therapeutics Inc(LTS:0L35)'s stock price today?
The current price of LTS:0L35 is $121.67. The 52 week high of LTS:0L35 is $175.10 and 52 week low is $88.01.
When is next earnings date of Sarepta Therapeutics Inc(LTS:0L35)?
The next earnings date of Sarepta Therapeutics Inc(LTS:0L35) is 2025-02-28 Est..
Does Sarepta Therapeutics Inc(LTS:0L35) pay dividends? If so, how much?
Sarepta Therapeutics Inc(LTS:0L35) does not pay dividend.

Press Release

Subject Date
No Press Release